Basic self-disturbance trajectories in clinical high risk for psychosis: a one-year follow-up study

Eur Arch Psychiatry Clin Neurosci. 2022 Sep;272(6):1007-1019. doi: 10.1007/s00406-021-01349-6. Epub 2021 Nov 16.

Abstract

Basic self-disturbance (BSD) has been proposed as a driver of symptom development in schizophrenia spectrum disorders (SSDs). In a one-year follow-up of 32 patients (15-30 years) at putative risk for psychosis, we investigated trajectories of BSD levels from baseline to follow-up, and associations between clinical characteristics at baseline and follow-up, including follow-up levels of BSD (assessed with the EASE). Clinical high risk (CHR) for psychosis status and symptom severity were assessed with the SIPS/SOPS scales and also according to the cognitive basic symptoms high-risk criteria (COGDIS). DSM-IV diagnoses, functioning and other clinical characteristics were assessed with standard clinical instruments. Higher severity of negative symptoms and meeting COGDIS criteria at baseline were associated with higher BSD levels at follow-up. All measured at follow-up, higher BSD levels correlated with higher severity of positive, negative, disorganization and general symptoms, and with a lower level of global functioning. We found higher BSD levels at follow-up in subjects with schizotypal personality disorder (SPD) at baseline (n = 5) and in SSDs at follow-up (n = 12, including nine with SPD). Mean BSD levels decreased significantly from baseline to follow-up, but individual trajectories varied considerably. Increased BSD levels were associated with higher baseline BSD levels, non-remission of positive symptoms and functional decline. Overall, the current study indicates that subgroups in the CHR population with a higher risk of non-remission or deterioration may be identified by supplementing CHR criteria with assessment of BSD and negative symptoms.

Keywords: Anomalous self-experience; Basic self-disturbance; Clinical high-risk for psychosis; Functioning; Negative symptoms; Schizophrenia spectrum.

MeSH terms

  • Follow-Up Studies
  • Humans
  • Prodromal Symptoms
  • Psychotic Disorders* / epidemiology
  • Risk Factors
  • Schizophrenia*
  • Schizotypal Personality Disorder* / diagnosis